News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,485 Results
Type
Article (42518)
Company Profile (198)
Press Release (707758)
Multimedia
Podcasts (103)
Webinars (21)
Section
Business (209174)
Career Advice (2070)
Deals (36287)
Drug Delivery (136)
Drug Development (82537)
Employer Resources (173)
FDA (16840)
Job Trends (15620)
News (353618)
Policy (33669)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2795)
Accelerated approval (59)
ADA (44)
Adcomms (31)
Allergies (197)
Alliances (50525)
ALS (229)
Alzheimer's disease (1901)
Antibody-drug conjugate (ADC) (537)
Approvals (17333)
Artificial intelligence (749)
ASCO (331)
Autoimmune disease (357)
Automation (66)
Bankruptcy (366)
Best Places to Work (12233)
BIO (73)
BIOSECURE Act (20)
Biosimilars (241)
Biotechnology (131)
Bladder cancer (206)
Brain cancer (78)
Breast cancer (824)
Cancer (6459)
Cardiovascular disease (515)
Career advice (1765)
Career pathing (45)
CAR-T (368)
CDC (59)
Celiac Disease (3)
Cell therapy (993)
Cervical cancer (57)
Clinical research (72325)
Collaboration (2298)
Commercialization (1)
Company closure (5)
Compensation (1529)
Complete response letters (87)
COVID-19 (2829)
CRISPR (118)
C-suite (1300)
Cystic fibrosis (159)
Data (8794)
Decentralized trials (3)
Denatured (30)
Depression (184)
Dermatology (101)
Diabetes (685)
Diagnostics (7293)
Digital health (67)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (376)
Drug pricing (204)
Drug shortages (31)
Duchenne muscular dystrophy (316)
Earnings (93427)
Editorial (68)
Employer branding (21)
Employer resources (155)
Events (124233)
Executive appointments (1161)
FDA (20998)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1917)
Gene editing (251)
Generative AI (64)
Gene therapy (773)
GLP-1 (1110)
Government (4932)
Grass and pollen (6)
Guidances (423)
Healthcare (20395)
Hematology (193)
HIV (90)
Huntington's disease (65)
IgA nephropathy (115)
Immunology and inflammation (313)
Immuno-oncology (109)
Indications (223)
Infectious disease (3206)
Inflammatory bowel disease (229)
Inflation Reduction Act (14)
Influenza (149)
Intellectual property (324)
Interviews (328)
IPO (17038)
IRA (50)
Job creations (3676)
Job search strategy (1457)
JPM (61)
Kidney cancer (21)
Labor market (112)
Layoffs (586)
Leadership (45)
Legal (8195)
Liver cancer (105)
Longevity (36)
Lung cancer (848)
Lymphoma (483)
Machine learning (66)
Management (61)
Manufacturing (1200)
Marketing (5)
MASH (211)
Medical affairs (1)
Medical device (14548)
Medtech (14728)
Mergers & acquisitions (20607)
Metabolic disorders (1685)
mRNA (239)
Multiple sclerosis (202)
NASH (18)
Neurodegenerative disease (468)
Neuropsychiatric disorders (111)
Neuroscience (3577)
Neurotech (1)
NextGen: Class of 2026 (7078)
Non-profit (4958)
Now hiring (83)
Obesity (772)
Opinion (305)
Ovarian cancer (243)
Pain (274)
Pancreatic cancer (362)
Parkinson's disease (403)
Partnered (37)
Patents (658)
Patient recruitment (798)
Peanut (68)
People (61484)
Pharmaceutical (47)
Pharmacy benefit managers (35)
Phase 1 (22589)
Phase 2 (31878)
Phase 3 (23655)
Pipeline (10113)
Policy (334)
Postmarket research (2590)
Preclinical (9594)
Press Release (72)
Prostate cancer (338)
Psychedelics (59)
Radiopharmaceuticals (356)
Rare diseases (1214)
Real estate (6114)
Recruiting (71)
Regulatory (26525)
Reports (56)
Research institute (2546)
Resumes & cover letters (360)
Rett syndrome (46)
RNA editing (25)
RSV (91)
Schizophrenia (189)
Series A (328)
Series B (239)
Service/supplier (7)
Sickle cell disease (123)
Special edition (33)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3735)
State (2)
Stomach cancer (19)
Supply chain (136)
Tariffs (87)
The Weekly (71)
Vaccines (1176)
Venture capital (124)
Weight loss (494)
Women's health (141)
Worklife (21)
Date
Today (85)
Last 7 days (426)
Last 30 days (2166)
Last 365 days (31014)
2026 (16953)
2025 (30705)
2024 (35894)
2023 (41058)
2022 (52188)
2021 (56975)
2020 (55912)
2019 (49245)
2018 (37147)
2017 (32843)
2016 (32416)
2015 (38417)
2014 (31543)
2013 (26549)
2012 (28762)
2011 (29460)
2010 (27497)
Location
Africa (772)
Alabama (101)
Alaska (7)
Arizona (374)
Arkansas (15)
Asia (41316)
Australia (6684)
California (14202)
Canada (4018)
China (1563)
Colorado (609)
Connecticut (620)
Delaware (441)
Europe (89654)
Florida (2162)
Georgia (459)
Hawaii (3)
Idaho (67)
Illinois (1206)
India (104)
Indiana (643)
Iowa (25)
Japan (611)
Kansas (140)
Kentucky (56)
Louisiana (60)
Maine (77)
Maryland (1709)
Massachusetts (10217)
Michigan (398)
Minnesota (795)
Mississippi (7)
Missouri (152)
Montana (37)
Nebraska (30)
Nevada (156)
New Hampshire (90)
New Jersey (3712)
New Mexico (32)
New York (3734)
North Carolina (1809)
North Dakota (10)
Northern California (7173)
Ohio (428)
Oklahoma (25)
Oregon (41)
Pennsylvania (2816)
Puerto Rico (32)
Rhode Island (53)
South America (1160)
South Carolina (91)
South Dakota (2)
Southern California (5649)
Tennessee (235)
Texas (2309)
United States (50371)
Utah (431)
Vermont (2)
Virginia (363)
Washington D.C. (83)
Washington State (1136)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
750,485 Results for "origin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall
June 22, 2026
·
6 min read
Press Releases
Laurent C.A. Melchior Tellier Returns to Original Role as CEO of Genomic Prediction
April 20, 2026
·
2 min read
Press Releases
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
June 2, 2026
·
6 min read
Press Releases
Shared origins illuminate potential dependency across brain tumor types
March 5, 2026
·
6 min read
Press Releases
Lynk Pharmaceuticals’ Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
June 9, 2026
·
3 min read
Press Releases
Cathy Tie Launches Origin Genomics to Advance Responsible Germline Gene Correction in the United States
March 19, 2026
·
2 min read
Regulatory
Amgen’s Tavneos troubles continue as
NEJM
retracts pivotal publication
Earlier this year, Amgen refused the FDA’s request to withdraw Tavneos from the market. Now, two researchers who participated in the original study to support the drug’s approval claim they did not know the primary endpoint was readjudicated after the study was unblinded.
June 30, 2026
·
2 min read
·
Tristan Manalac
China
BIO outshines World Cup as biotech celebrates 50th anniversary with a ‘call to action’
At the BIO International Convention in San Diego, attendees marked the 50th anniversary of original biotech Genentech, reflecting on the immense challenges facing companies as China becomes a powerhouse innovator.
June 30, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
December 11, 2025
·
7 min read
Press Releases
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
September 26, 2025
·
5 min read
1 of 75,049
Next
